Article
Detection of large rearrangements in the cystic fibrosis transmembrane conductance regulator gene by multiplex ligation-dependent probe amplification assay when sequencing fails to detect two disease-causing mutations.
Genetic testing and molecular biomarkers - 1 Apr 2010
Svensson Annika M, Chou Lan-Szu, Miller Christine E, Robles Jorge A, Swensen Jeffrey J, Voelkerding Karl V, Mao Rong, Lyon Elaine
Abstract excerpt
AIMS: Most of the over 1600 mutations and sequence variants identified to date in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are point mutations or small deletions/insertions detectable by conventional sequencing. However, large rearrangements (deletions, duplications, or insertion/deletion mutations) have recently been reported to constitute 1-2% of CFTR mutations. The CFTR sequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
